Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Drugging the lymphatic system: An emerging opportunity for cancer immunotherapy

Advanced Drug Delivery Reviews(2021)10.1016/j.addr.2021.114040Source: DataRank Database

Drugging the lymphatic system: An emerging opportunity for cancer immunotherapy is a research paper published in Advanced Drug Delivery Reviews (2021). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)OA: bronzeTopics (8)IDs (PubMed)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Susan N. Thomas ORCID,Takashi Nakamura ORCID

Live enrichment

PubMed:34763001

Japan Society for the Promotion of Science

NIH

bronzeLicense: http://www.elsevier.com/open-access/userlicense/1.0/

publisherhttps://www.sciencedirect.com/science/article/am/pii/S0169409X21004336?via%3Dihub

publisherhttps://api.elsevier.com/content/article/PII:S0169409X21004336?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0169409X21004336?httpAccept=text/plain

Fields of Study

HumansImmunotherapyLymphatic SystemNeoplasms

MeSH Terms

Lymphatic SystemHumansNeoplasmsImmunotherapy